Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: A canadian cancer institute experience

Clinical Colorectal Cancer

Volumn 13, Issue 3, 2014, Pages 199-206

  Kim, Christina A K ^a   Spratlin, Jennifer L ^a   Armstrong, Dawn E ^a   Ghosh, Sunita ^a   Mulder, Karen E ^a  

^a CROSS CANCER INSTITUTE   (Canada)

Author keywords

Adjuvant chemotherapy; Combination therapy; Elderly; Survival; Toxicity

Indexed keywords

CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; PLATINUM COMPLEX; VITAMIN B COMPLEX;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COLON CANCER; COMORBIDITY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HAND FOOT SYNDROME; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT PREFERENCE; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CANADA; CANCER STAGING; COLONIC NEOPLASMS; DECISION MAKING; DISEASE FREE SURVIVAL; INSURANCE; PATHOLOGY; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANADA; CHEMOTHERAPY, ADJUVANT; CHOICE BEHAVIOR; COLONIC NEOPLASMS; COMORBIDITY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; LEUCOVORIN; MALE; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PATIENT PREFERENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; VITAMIN B COMPLEX;

EID: 84908207384     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2014.06.002     Document Type: Article

References (14)

1. National Cancer Institute. SEER Cancer Statistics Factsheets: colon and Rectum Cancer. Available at: http://seer.cancer.gov/statfacts/html/colorect.html. Accessed: April 10, 2014.
2. L.A. Gloeckler Ries, M.E. Reichman, D.R. Lewis, B.F. Hankey, and B.K. Edwards Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program Oncologist 8 2003 541 552
3. C.G. Moertel, T.R. Fleming, and J.S. Macdonald Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 1990 352 358
4. T. Andre, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
5. T. Andre, C. Boni, and M. Navarro Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 2009 3109 3116
6. A.E. Stuck, A.L. Siu, G.D. Wieland, J. Adams, and L.Z. Rubenstein Comprehensive geriatric assessment: a meta-analysis of controlled trials Lancet 342 1993 1032 1036
7. A. Hurria, S. Gupta, and M. Zauderer Developing a cancer-specific geriatric assessment: a feasibility study Cancer 104 2005 1998 2005
8. N.J. McCleary, D. Wigler, and D. Berry Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy Oncologist 18 2013 64 72
9. A. Hurria, K. Togawa, and S.G. Mohile Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study J Clin Oncol 29 2011 3457 3465
10. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006 (based on November 2008 SEER data submission, posted to the SEER web site, 2009). National Cancer Institute, Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2006/. Accessed: July 4, 2014.
11. R. Yancik, M.N. Wesley, and L.A. Ries Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study Cancer 82 1998 2123 2134
12. C.P. Gross, G.J. McAvay, H.M. Krumholz, A.D. Paltiel, D. Bhasin, and M.E. Tinetti The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening Ann Intern Med 145 2006 646 653
13. S.A. Dobie, L.M. Baldwin, J.A. Dominitz, B. Matthews, K. Billingsley, and W. Barlow Completion of therapy by Medicare patients with stage III colon cancer J Natl Cancer Inst 98 2006 610 619
14. N.J. McCleary, J.A. Meyerhardt, and E. Green Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database J Clin Oncol 31 2013 2600 2606